Fake Ayurvedic drugs seized of worth Rs 11 Lakh by Maha FDA

Maharashtra Food and Drug Administration during their raid on companies for flouting norms seized spurious drugs of worth Rs 11 lakhs. All the fake medicines are collected from retail outlets of 13 ayurvedic manufacturers in Maharashtra in contravention of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 (DMR Act).

All the seized medicines have the manufacturing based in J&K, Punjab, Madhya Pradesh, Uttarakhand, Rajasthan, Gujarat, and Maharashtra. Fake medicines that were found are Follivita 52 tablet manufactured by New Life Laboratories Pvt Ltd, Ratisutra capsule and gel worth Rs.24,000 of Gujarat based Ayulab Pvt Ltd and drugs worth Rs.1, 35,000 of a firm based in Gujarat manufacturing drugs with label claims in the Gujarati language for treating various ailments.

It’s time to just be aware from fake medicines and its great success of Maharashtra FDA. Seized drugs also include spurious drugs with the name Susten 400 capsules and Seleg tablets worth Rs.4,11,000 of Haridwar based Akum Drug and Pharmaceuticals Ltd and fake drug Fat Go capsule worth Rs.26,225 from Jolly Healthcare having manufacturing unit in Punjab.

In the raid of a firm in Vasai, Maharashtra running by the name of Anandi Pharmaceuticals manufacturing also have spurious drug under the brand name Play Win capsule. It also seized Metaslim Ayurvedic Weight Control Powder and Massage oil worth Rs.48,000 manufactured by Fortune Pharmaceuticals India Pvt Ltd having manufacturing unit in J&K.

Its a major crackdown by Maha FDA and there are many more spurious drugs like Jambola liquid manufactured by Luna pharma having the manufacturing base in Rajasthan, Medari Slim fit syrup manufactured by Abhay Ayurvedic based in Osmanabad, Maharashtra, Play Win capsules by Arihant Remedies having manufacturing unit in Gujarat, also get seized in the raids.

India has act named “DMR Act, 1954” of the Parliament of India controls advertising of drugs in India. It keeps checks on the fake advertisements of medicines and remedies that claim to have magical properties and makes doing so a cognizable offense.

The Act defines magic remedy as any talisman, mantra, amulet or any other object which is claimed to have miraculous powers to cure, diagnose, prevent or mitigate a disease in humans or animal. It also includes such devices that are claimed to have the power to influence structure or function of an organ in humans or animals.

The law controls the advertising of medicines and remedies for inducing miscarriage or preventing conception in women, improving or maintaining the capacity for sexual pleasure, correction of menstrual disorders, curing, diagnosing or preventing any disease or condition among others.

Related Posts

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

New Delhi: In a major crackdown on the sale of expired and substandard products, the Central Range team of Delhi Police Crime Branch has arrested one person and seized nearly…

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

Washington:  On March 18, 2026, the U.S. Food and Drug Administration (FDA) issued a draft guidance titled General Considerations for the Use of New Approach Methodologies in Drug Development. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

IPC releases draft NFI-2026 to promote rational use of medicines

IPC releases draft NFI-2026 to promote rational use of medicines

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

US market to dent India pharma earnings even as domestic growth remains firm

US market to dent India pharma earnings even as domestic growth remains firm

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg